Clinical Trials Directory

Trials / Completed

CompletedNCT01616407

Effects of MDMA and Methylphenidate on Social Cognition

Effects of MDMA (Ecstasy) and Methylphenidate (Ritalin) on Social Cognition

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess and compare the effects of a single dose of 3,4-methylenedioxymethamphetamine (MDMA)and methylphenidate (MPH) on emotional and social cognition in healthy subjects. The investigators hypothesize that MDMA enhances affective perception for positive and impairs perception for negative emotional stimuli compared to placebo or MPH.

Conditions

Interventions

TypeNameDescription
DRUG3,4-Methylenedioxymethamphetamine75 mg per os, single dose
DRUGMethylphenidate40 mg per os, single dose
DRUGPlacebocapsules identical to MDMA or methylphenidate but containing no active drug

Timeline

Start date
2012-08-01
Primary completion
2012-12-01
Completion
2013-04-01
First posted
2012-06-11
Last updated
2018-12-11

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01616407. Inclusion in this directory is not an endorsement.